ClinicalTrials.gov
ClinicalTrials.gov Menu

Quality of Life in Younger Leukemia and Lymphoma Survivors

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00956475
Recruitment Status : Completed
First Posted : August 11, 2009
Last Update Posted : August 24, 2011
Sponsor:
Collaborator:
National Cancer Institute (NCI)
Information provided by (Responsible Party):
Case Comprehensive Cancer Center

August 8, 2009
August 11, 2009
August 24, 2011
October 2008
September 2010   (Final data collection date for primary outcome measure)
  • Quality of life [ Time Frame: 1-10 years after treatment ]
  • Most common areas of concern [ Time Frame: 1-10 years after treatment ]
  • Quality of life
  • Most common areas of concern
Complete list of historical versions of study NCT00956475 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
Quality of Life in Younger Leukemia and Lymphoma Survivors
Quality of Life in Young Adult Survivors of Hematologic Malignancies

RATIONALE: Collecting information about the effect of hematologic cancer and its treatment on quality of life may help doctors learn more about the disease and plan the best treatment.

PURPOSE: This phase I trial is studying quality of life in younger leukemia and lymphoma survivors.

OBJECTIVES:

  • To collect preliminary data to determine the extent to which there is impairment in quality of life of young adult survivors of hematologic malignancies.
  • To identify the most common areas of concern in these survivors.
  • To explore patterns of quality-of-life impairment associated with age, gender, and type of treatment (transplant vs non-transplant) in these survivors.

OUTLINE: Patients are assessed in a telephone interview using a brief demographic and clinical data form. Patients then undergo quality-of-life assessment by the Cancer Patient/Cancer Survivor Version questionnaire via telephone.

Observational
Observational Model: Case-Only
Time Perspective: Cross-Sectional
Not Provided
Not Provided
Probability Sample
Records from the practice of the study investigators will be reviewed to identify patients.
  • Anxiety Disorder
  • Cancer Survivor
  • Fatigue
  • Leukemia
  • Long-term Effects Secondary to Cancer Therapy in Adults
  • Lymphoma
  • Lymphoproliferative Disorder
  • Pain
  • Psychosocial Effects of Cancer and Its Treatment
  • Small Intestine Cancer
  • Behavioral: telephone-based intervention
    Patients are assessed in a telephone interview using a brief demographic and clinical data form. Patients then undergo quality-of-life assessment by the Cancer Patient/Cancer Survivor Version questionnaire via telephone.
  • Other: questionnaire administration
    Patients are assessed in a telephone interview using a brief demographic and clinical data form. Patients then undergo quality-of-life assessment by the Cancer Patient/Cancer Survivor Version questionnaire via telephone.
  • Procedure: assessment of therapy complications
    questionnaire via telephone
  • Procedure: fatigue assessment and management
    questionnaire via telephone
  • Procedure: psychosocial assessment and care
    questionnaire via telephone
  • Procedure: quality-of-life assessment
    questionnaire via telephone
Not Provided
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
48
50
August 2011
September 2010   (Final data collection date for primary outcome measure)

DISEASE CHARACTERISTICS:

  • Survivors of leukemia (i.e., acute myelogenous leukemia, acute lymphoblastic leukemia, chronic myelogenous leukemia, or chronic lymphocytic leukemia) or lymphoma (i.e., non-Hodgkin lymphoma or Hodgkin lymphoma) who have received any cytotoxic or radiation therapy
  • Received treatment for leukemia or lymphoma 1-10 years ago

PATIENT CHARACTERISTICS:

  • Not specified

PRIOR CONCURRENT THERAPY:

  • See Disease Characteristics
Sexes Eligible for Study: All
18 Years to 35 Years   (Adult)
No
Contact information is only displayed when the study is recruiting subjects
United States
 
 
NCT00956475
CASE11Z08
P30CA043703 ( U.S. NIH Grant/Contract )
CASE11Z08 ( Other Identifier: Case Comprehensive Cancer Center )
CASE 11Z08-CC607 ( Other Identifier: Cancer Center IRB )
Yes
Not Provided
Not Provided
Case Comprehensive Cancer Center
Case Comprehensive Cancer Center
National Cancer Institute (NCI)
Principal Investigator: Regan Demshar, RN Case Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center
Case Comprehensive Cancer Center
August 2011